Page last updated: 2024-09-04

atrasentan and abiraterone

atrasentan has been researched along with abiraterone in 1 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(abiraterone)
Trials
(abiraterone)
Recent Studies (post-2010) (abiraterone)
3584110894297854

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)abiraterone (IC50)
Steroid 17-alpha-hydroxylase/17,20 lyaseHomo sapiens (human)0.2557
Cytochrome P450 3A4Homo sapiens (human)2.0643
Steroid 21-hydroxylaseHomo sapiens (human)0.1642
Steroid 17-alpha-hydroxylase/17,20 lyase Rattus norvegicus (Norway rat)0.0674
Cytochrome P450 11B1, mitochondrialHomo sapiens (human)1.5714
Cytochrome P450 11B2, mitochondrialHomo sapiens (human)1.722

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corn, PG; Dayyani, F; Gallick, GE; Logothetis, CJ1

Reviews

1 review(s) available for atrasentan and abiraterone

ArticleYear
Novel therapies for metastatic castrate-resistant prostate cancer.
    Journal of the National Cancer Institute, 2011, Nov-16, Volume: 103, Issue:22

    Topics: Androstenes; Androstenols; Angiogenesis Inhibitors; Anilides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Atrasentan; Benzamides; Bevacizumab; Biomarkers, Tumor; Bone Remodeling; Cancer Vaccines; Clinical Trials as Topic; Clusterin; Dasatinib; Denosumab; Endothelin-1; Humans; Immunotherapy; Indoles; Ipilimumab; Male; Mice; Mice, SCID; Molecular Targeted Therapy; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Pyrimidines; Pyrroles; Pyrrolidines; RANK Ligand; Receptor Cross-Talk; Receptors, Androgen; Signal Transduction; Sunitinib; Taxoids; Thiazoles; Tissue Extracts; Treatment Failure; Tumor Microenvironment; Xenograft Model Antitumor Assays

2011